中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | O-phenyl {[(benzyloxy)carbonyl]amino}(phenyl)methylphosphonate | 82629-35-4 | C21H20NO5P | 397.367 |
—— | O-benzyl O-phenyl {[(benzyloxy)carbonyl]amino}(phenyl)methylphosphonate | 472966-62-4 | C28H26NO5P | 487.492 |
—— | diphenyl [1-(1-amino)benzyl]phosphonate | 84044-04-2 | C19H18NO3P | 339.331 |
—— | n-undecyl phenyl (benzyloxycarbonylamino)(phenyl)methylphosphonate | —— | C32H42NO5P | 551.663 |
O,O-二甲基{[(苄氧基)羰基]氨基}(苯基)甲基膦酸酯 | Dimethyl α-benzyloxycarbonylaminobenzylphosphonate | 59191-30-9 | C17H20NO5P | 349.323 |
—— | O-phenyl N-isoamyl-P-[{[(benzyloxy)carbonyl]amino}(phenyl)methyl]phosphonamidate | 472966-60-2 | C26H31N2O4P | 466.517 |
—— | diphenyl (isothiocyanato(phenyl)methyl)phosphonate | 1403781-79-2 | C20H16NO3PS | 381.392 |
—— | O-phenyl N-benzyl-P-[{[(benzyloxy)carbonyl]amino}(phenyl)methyl]phosphonamidate | 472966-59-9 | C28H27N2O4P | 486.507 |
—— | benzyl N-[(S)-[(benzylamino)-oxido-phenoxyphosphaniumyl]-phenylmethyl]carbamate | 472966-71-5 | C28H27N2O4P | 486.507 |
—— | O-phenyl N-phenyl-P-[{[(benzyloxy)carbonyl]amino}(phenyl)methyl]phosphonamidate | 472966-58-8 | C27H25N2O4P | 472.48 |
—— | benzyl ((diethoxyphosphoryl)(phenyl)methyl)carbamate | 38428-05-6 | C19H24NO5P | 377.377 |
—— | (Formylamino-phenyl-methyl)-phosphonic acid diphenyl ester | 901773-70-4 | C20H18NO4P | 367.341 |
—— | methyl N-[[{[(benzyloxy)carbonyl]amino}(phenyl)methyl](phenoxy)phosphoryl]-L-valinate | 472966-61-3 | C27H31N2O6P | 510.527 |
Enzyme specific inhibitors can be designed based on endogenous substrate peptide motifs and modified to yield specific activity-based probes (ABPs). The development/validation of a theranostic ABP-inhibitor prototype for KLK7 protease is presented.